Your browser is no longer supported. Please, upgrade your browser.
Settings
RGEN Repligen Corporation daily Stock Chart
RGEN [NASD]
Repligen Corporation
Index- P/E199.30 EPS (ttm)0.30 Insider Own1.40% Shs Outstand43.49M Perf Week4.68%
Market Cap2.62B Forward P/E71.15 EPS next Y0.85 Insider Trans-12.22% Shs Float39.41M Perf Month8.26%
Income13.60M PEG7.97 EPS next Q0.21 Inst Own97.60% Short Float10.00% Perf Quarter-7.95%
Sales183.70M P/S14.25 EPS this Y39.90% Inst Trans0.86% Short Ratio9.74 Perf Half Y22.64%
Book/sh13.84 P/B4.35 EPS next Y16.69% ROA3.10% Target Price64.63 Perf Year82.45%
Cash/sh- P/C- EPS next 5Y25.00% ROE3.90% 52W Range31.46 - 70.50 Perf YTD14.13%
Dividend- P/FCF81.55 EPS past 5Y1.10% ROI3.70% 52W High-14.62% Beta1.09
Dividend %- Quick Ratio1.70 Sales past 5Y17.80% Gross Margin55.30% 52W Low91.32% ATR1.77
Employees476 Current Ratio2.10 Sales Q/Q35.20% Oper. Margin11.60% RSI (14)60.77 Volatility3.44% 3.25%
OptionableYes Debt/Eq0.17 EPS Q/Q-4.60% Profit Margin12.60% Rel Volume1.06 Prev Close58.82
ShortableYes LT Debt/Eq0.00 EarningsFeb 21 BMO Payout0.00% Avg Volume404.50K Price60.19
Recom1.80 SMA205.26% SMA507.49% SMA20014.32% Volume428,174 Change2.33%
Dec-17-18Upgrade CL King Neutral → Buy
Nov-12-18Downgrade CL King Buy → Neutral
Sep-26-18Initiated H.C. Wainwright Neutral $49
Dec-08-17Initiated Citigroup Buy $45
Dec-05-17Initiated JP Morgan Overweight $42
Nov-13-17Initiated CL King Buy
Oct-02-17Upgrade First Analysis Sec Equal-Weight → Overweight $47
Jul-21-17Initiated William Blair Outperform
Feb-13-17Upgrade Piper Jaffray Neutral → Overweight
Feb-22-16Initiated Craig Hallum Buy
Nov-06-15Downgrade Jefferies Buy → Hold
Apr-23-15Reiterated Jefferies Buy $25 → $38
Mar-07-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-30-09Initiated Merriman Buy
Jun-12-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
Sep-10-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
Apr-12-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
Feb-15-19 07:30AM  Repligen to Report Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Jan-30-19 11:48AM  Is Repligen Corporations (NASDAQ:RGEN) Liquidity Good Enough? Simply Wall St.
Jan-28-19 08:00AM  Today's Research Reports on Trending Tickers: Incyte and Repligen ACCESSWIRE -5.14%
Jan-25-19 12:21PM  3 Pick-and-Shovel Biotechnology Stocks Motley Fool
Jan-24-19 06:40PM  How to Play It Safe in Biotech Motley Fool
Jan-23-19 07:35AM  Consolidated Research: 2019 Summary Expectations for Post, Westlake Chemical, Repligen, Weingarten Realty Investors, AptarGroup, and At Home Group Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-10-19 05:00AM  Top Picks 2019- Repligen RGEN MoneyShow
Jan-03-19 01:26PM  Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-23-18 04:27AM  Is Repligen Corporation (RGEN) A Good Stock To Buy? Insider Monkey
Dec-20-18 12:00PM  Have Insiders Been Selling Repligen Corporation (NASDAQ:RGEN) Shares This Year? Simply Wall St.
Dec-17-18 09:30AM  ANIK vs. RGEN: Which Stock Should Value Investors Buy Now? Zacks -5.39%
Nov-20-18 11:57AM  Based On Its ROE, Is Repligen Corporation (NASDAQ:RGEN) A High Quality Stock? Simply Wall St.
Nov-16-18 02:15PM  Trump Trade Comments Boost Dow Jones; These 6 Growth Stocks Take Market Helm Investor's Business Daily
Nov-12-18 08:15AM  Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-11-18 11:25AM  Edited Transcript of RGEN earnings conference call or presentation 1-Nov-18 12:30pm GMT Thomson Reuters StreetEvents
Nov-09-18 01:25PM  Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018 Investor's Business Daily
Nov-04-18 06:49PM  3 Growth Stocks for In-the-Know Investors Motley Fool
Nov-02-18 08:01AM  The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug Benzinga
Nov-01-18 04:19PM  IBD Stock Of The Day Breaks Out On Strong Quarterly Report, Outlook Investor's Business Daily +17.21%
12:22PM  Here's Why Repligen Rose More Than 16% Today Motley Fool
08:09AM  Repligen: 3Q Earnings Snapshot Associated Press
07:30AM  Repligen Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-22-18 07:30AM  Repligen to Report Third Quarter 2018 Financial Results GlobeNewswire
Oct-17-18 08:25AM  Recent Analysis Shows Repligen, SpartanNash, AZUL SA, Pacira Pharmaceuticals, Ichor, and Scorpio Tankers Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-05-18 08:49AM  Repligen Corporation (NASDAQ:RGEN): Earnings To Drop Next Year Simply Wall St.
Aug-22-18 08:15AM  Recent Analysis Shows STMicroelectronics N.V, Jagged Peak Energy, Inovalon, AC Immune SA, Repligen, and RealNetworks Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Aug-03-18 09:19PM  Edited Transcript of RGEN earnings conference call or presentation 2-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-02-18 12:55PM  Repligen (RGEN) Misses Q2 Earnings Estimates Zacks
11:49AM  Repligen: 2Q Earnings Snapshot Associated Press
07:30AM  Repligen Reports Second Quarter 2018 Financial Results GlobeNewswire
06:30AM  Repligen Corporation to Host Earnings Call ACCESSWIRE
Aug-01-18 08:00AM  Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Repligen ACCESSWIRE
Jul-19-18 11:48AM  Repligen to Report Second Quarter 2018 Financial Results GlobeNewswire
Jun-28-18 07:35AM  Purolite Life Sciences Announces the Launch of Praesto® Jetted A50 Using Proprietary Jetting Technology - Leading the Future of Protein A Chromatography Resins PR Newswire
07:30AM  Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand GlobeNewswire
Jun-27-18 07:30AM  Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands GlobeNewswire
Jun-19-18 01:25PM  CVS will offer home delivery of prescriptions Yahoo Finance Video
Jun-11-18 07:50AM  Report: Exploring Fundamental Drivers Behind Matthews International, Raytheon, JetBlue Airways, Repligen, Becton, Dickinson, and Macy's New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
May-30-18 07:30AM  Repligen to Present at the William Blair 2018 Growth Stock Conference GlobeNewswire
May-23-18 07:34AM  Moving Average Crossover Alert: Repligen (RGEN) Zacks
07:30AM  Repligen to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-17-18 07:30AM  Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference GlobeNewswire
May-10-18 07:46AM  Edited Transcript of RGEN earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-08-18 07:59AM  Repligen: 1Q Earnings Snapshot Associated Press +5.66%
07:30AM  Repligen Reports First Quarter 2018 Financial Results GlobeNewswire
May-01-18 09:52AM  Biotechnology Movers: Karyopharm Therapeutics Inc. and Regeneron Pharmaceuticals Market Exclusive
07:35AM  Analysis: Positioning to Benefit within USA Compression Partners, LP, Kadmon, Repligen, Independent Bank, Leggett & Platt, and Esterline Technologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Apr-30-18 11:00AM  Repligen to Report First Quarter 2018 Financial Results GlobeNewswire
Apr-26-18 10:50AM  3 Top Growth Stocks to Buy Right Now Motley Fool
Apr-24-18 07:47AM  3 Top Stocks You Can Buy and Hold for the Next Decade Motley Fool
Apr-12-18 06:33AM  My Investing Horror Story: Selling Too Early Motley Fool
Apr-03-18 04:55PM  Should You Be Tempted To Sell Repligen Corporation (NASDAQ:RGEN) Because Of Its PE Ratio? Simply Wall St.
Mar-26-18 06:48PM  Repligen Corporation (NASDAQ:RGEN): Is It A Good Long Term Opportunity? Simply Wall St.
Mar-20-18 07:30AM  Repligen Announces Market Launch of OPUS® 80R, Reinforces Technology Leadership in Pre-Packed Chromatography GlobeNewswire
07:30AM  Analysis: Positioning to Benefit within Clearwater Paper, Energous, MINDBODY, Agilysys, Repligen, and Unit Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-16-18 04:38PM  Will Repligen Corporations (NASDAQ:RGEN) Earnings Grow In The Year Ahead? Simply Wall St.
Feb-23-18 03:02AM  Edited Transcript of RGEN earnings conference call or presentation 22-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
Feb-22-18 08:43AM  Repligen beats Street 4Q forecasts Associated Press +7.96%
07:30AM  Repligen Reports Fourth Quarter 2017 Financial Results, Provides Guidance for 2018 GlobeNewswire
06:40AM  Repligen Corporation to Host Earnings Call ACCESSWIRE
Feb-16-18 07:30AM  Repligen to Report Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Jan-17-18 07:50AM  Report: Developing Opportunities within Repligen, Avid Technology, Reata Pharmaceuticals, Stellus Capital Investment, American Financial Group, and Actuant Future Expectations, Projections Moving into 2018 GlobeNewswire
Jan-02-18 08:04AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Dec-29-17 01:47PM  Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
12:28PM  ETFs with exposure to Repligen Corp. : December 29, 2017 Capital Cube
Dec-28-17 09:23AM  Repligen Corp. :RGEN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 28, 2017 Capital Cube
Dec-20-17 06:34AM  3 Growth Stocks to Buy for 2018 Motley Fool
Dec-19-17 02:45PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : December 19, 2017 Capital Cube
Dec-18-17 08:03AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : December 18, 2017 Capital Cube
Dec-13-17 06:54PM  Why Repligen Corporations (NASDAQ:RGEN) ROE Of 5.70% Does Not Tell The Whole Story Simply Wall St.
Dec-10-17 03:59PM  Top 3 Healthcare Penny Stocks for 2017 Investopedia
Dec-07-17 09:00AM  3 Growth Stocks to Buy and Hold for 25 Years Motley Fool
Nov-29-17 09:16AM  3 Bioeconomy Stocks That Have a Killer Advantage Motley Fool
Nov-28-17 08:03AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Nov-16-17 07:20AM  Featured Company News - TapImmune Announced Final Patient Enrollment Ahead of Schedule in Phase-2 Cancer Vaccine Study For TNBC ACCESSWIRE
Nov-15-17 08:08AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Nov-13-17 03:38AM  Edited Transcript of RGEN earnings conference call or presentation 9-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-09-17 08:04AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
07:43AM  Repligen tops Street 3Q forecasts Associated Press
07:30AM  Repligen Reports Third Quarter 2017 Financial Results GlobeNewswire
07:00AM  Repligen Corporation to Host Earnings Call ACCESSWIRE
Nov-08-17 12:20PM  Top 3 Healthcare Penny Stocks for 2017 Investopedia
08:58AM  Should You Sell Repligen Corporation (RGEN) Before Earnings? Zacks
Nov-07-17 11:07AM  5 Biotech Stocks Well Poised to Surpass Expectations in Q3 Zacks
07:30AM  Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands GlobeNewswire
Nov-06-17 08:04AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Nov-01-17 12:36PM  ETFs with exposure to Repligen Corp. : November 1, 2017 Capital Cube
11:14AM  Repligen to Report Third Quarter 2017 Financial Results GlobeNewswire
07:58AM  Purolite Selects Repligen's Market-Leading OPUS® Pre-Packed Columns PR Newswire
Oct-31-17 03:00AM  Stocks With Rising Relative Strength: Repligen Investor's Business Daily
Oct-26-17 08:02AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Oct-20-17 10:24AM  ETFs with exposure to Repligen Corp. : October 20, 2017 Capital Cube
Oct-17-17 08:02AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit -5.16%
Oct-16-17 09:41AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Oct-09-17 11:59AM  ETFs with exposure to Repligen Corp. : October 9, 2017 Capital Cube
Oct-02-17 08:03AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Sep-28-17 10:19AM  ETFs with exposure to Repligen Corp. : September 28, 2017 Capital Cube
Sep-27-17 09:04AM  Repligen Corp. :RGEN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017 Capital Cube
08:18AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : September 27, 2017 Capital Cube
Sep-15-17 07:30AM  Repligen Announces Analyst Day and Webcast GlobeNewswire
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process worldwide. It offers Protein A ligands to life sciences companies, which are the binding components of Protein A affinity resins; and growth factor products used to supplement cell culture media. The company also provides chromatography products comprising OPUS pre-packed chromatography columns, which are used in the purification of antibodies and recombinant proteins; and OPUS PD smaller-scale columns that are used in the high throughput process development screening, viral validation studies, and scale down validation of chromatography processes. Its chromatography products also comprise ELISA kits, which are analytical test kits to detect the presence of proteins and growth factors; chromatography resins under the CaptivA brand; and liquid chromatography products under the Spectra/Chrom brand. In addition, the company provides filtration products, such as XCell ATF systems that are filtration devices used in upstream processes to remove cellular metabolic waste products during the course of a fermentation run, freeing healthy cells to continue producing the biologic drug of interest; Sius TFF line of cassettes used in downstream biologic drug purification and formulation processes; KrosFlo line of hollow-fiber cartridges and TFF systems; Spectra/Por portfolio of laboratory and process dialysis products; and Pro-Connex single-use hollow-fiber module-bag-tubing sets. Repligen Corporation sells its bioprocessing products to life sciences companies, biopharmaceutical companies, and contract manufacturing organizations. The company has a collaboration agreement with Navigo Proteins GmbH for the advancement of affinity ligands used in monoclonal antibody (mAb) and non-mAb downstream purification processes. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KURIYEL RALFSenior VP, R&DDec 18Sale54.4431116,93112,294Dec 20 04:22 PM
Snodgres JonCFONov 26Option Exercise27.1231,753861,13252,652Nov 28 04:43 PM
Snodgres JonCFONov 26Sale63.4931,7532,015,91520,899Nov 28 04:43 PM
RYAN THOMAS F JRDirectorNov 05Sale65.751,763115,9203,225Nov 06 06:29 PM
Hunt AnthonyChief Executive OfficerSep 10Option Exercise16.5511,873196,498255,017Sep 12 04:15 PM
Hunt AnthonyChief Executive OfficerSep 10Sale57.7127,5661,590,809227,451Sep 12 04:15 PM
BARTHELEMY NICOLASDirectorAug 29Option Exercise39.854,426176,39210,766Aug 31 04:15 PM
BARTHELEMY NICOLASDirectorAug 29Sale54.446,580358,1964,186Aug 31 04:15 PM
Snodgres JonCFOAug 28Sale52.7914,460763,35920,899Aug 29 04:15 PM
RYAN THOMAS F JRDirectorAug 22Sale51.442,366121,6984,988Aug 24 04:16 PM
EDDLEMAN ROY T10% OwnerAug 09Sale49.63116,0735,760,536370,000Aug 13 04:06 PM
EDDLEMAN ROY T10% OwnerAug 08Sale49.054,770233,970409,215Aug 08 06:10 PM
EDDLEMAN ROY T10% OwnerAug 07Sale49.0516,015785,577413,985Aug 08 06:10 PM
EDDLEMAN ROY T10% OwnerAug 06Sale49.0533,1421,625,599796,858Aug 08 06:10 PM
RYAN THOMAS F JRDirectorJun 06Sale44.311,93285,6067,354Jun 07 04:28 PM
Hunt AnthonyChief Executive OfficerMay 21Sale42.5316,249691,016243,144May 22 05:12 PM
EDDLEMAN ROY T10% OwnerMay 16Sale42.07118,8505,000,0202,925,976May 18 10:46 AM
DAWES KAREN ADirectorMay 11Option Exercise5.0820,000101,600114,957May 15 09:53 AM
DAWES KAREN ADirectorMay 11Sale41.8020,000835,93694,957May 15 09:53 AM
BARTHELEMY NICOLASDirectorMay 09Option Exercise21.0827,366576,80031,354May 11 10:38 AM
EDDLEMAN ROY T10% OwnerMay 09Sale40.4445,7731,850,972410,000May 09 06:59 PM
BARTHELEMY NICOLASDirectorMay 09Sale40.5426,5001,074,2384,854May 11 10:38 AM
EDDLEMAN ROY T10% OwnerMay 08Sale40.7374,2273,023,485430,773May 09 06:59 PM
RYAN THOMAS F JRDirectorMar 08Option Exercise14.954,69670,19213,396Mar 12 05:32 PM
RYAN THOMAS F JRDirectorMar 08Sale36.164,696169,7928,700Mar 12 05:32 PM